Parshwa Organo Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-12-2024
- Paid Up Capital ₹ 2.55 M
as on 07-12-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 Cr
as on 07-12-2024
- Revenue 239.01%
(FY 2023)
- Profit 51826.02%
(FY 2023)
- Ebitda 815.53%
(FY 2023)
- Net Worth 785.64%
(FY 2023)
- Total Assets 79.86%
(FY 2023)
About Parshwa Organo Biotech
The Corporate was formerly known as Rdh Organo Biotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.55 M.
The company currently has active open charges totaling ₹1.60 Cr.
Hiren Poladia, Yash Savla, Chaitya Poladia, and One other member serve as directors at the Company.
- CIN/LLPIN
U24132MH1998PTC113991
- Company No.
113991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Parshwa Organo Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hiren Poladia  | Director | 19-Mar-1998 | Current |
| Yash Savla | Director | 21-Nov-2019 | Current |
| Chaitya Poladia | Director | 01-Jul-2023 | Current |
| Nirav Poladia | Director | 01-Jul-2023 | Current |
Financial Performance of Parshwa Organo Biotech.
Parshwa Organo Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 239.01% increase. The company also saw a substantial improvement in profitability, with a 51826.02% increase in profit. The company's net worth Soared by an impressive increase of 785.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parshwa Organo Biotech?
In 2023, Parshwa Organo Biotech had a public holding of 34.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Feb 2024 | ₹1.11 M | Open |
Others Creation Date: 21 Oct 2023 | ₹2.00 M | Open |
Others Creation Date: 07 Sep 2023 | ₹0.94 M | Open |
How Many Employees Work at Parshwa Organo Biotech?
Parshwa Organo Biotech has a workforce of 11 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parshwa Organo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parshwa Organo Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
